参考文献/References:
[1] Im E,Kim BK,Ko YG,et al. Incidences,predictors,and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation[J]. Circ Cardiovasc Interv,2014,7(1):88-96.
[2] Sarno G,Lagerqvist B,Nilsson J,et al. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI:a report from SCAAR[J]. J Am Coll Cardiol,2014,64(1):16-24.
[3] Prati F,Romagnoli E,Burzotta F,et al. Clinical impact of OCT findings during PCI:the CLI-OPCI Ⅱ study [J]. JACC Cardiovasc Imaging,2015,8(11):1297-1305.
[4] Romagnoli E,Gatto L,La Manna A,et al. Role of residual acute stent malapposition in percutaneous coronary interventions[J]. Catheter Cardiovasc Interv,2017,90(4):566-575.
[5] Mintz GS. Why are we so concerned with acute incomplete stent apposition?[J]. Eur Heart J Cardiovasc Imaging,2015,16(1):110-111.
[6] Foin N,Lu S,Ng J,et al. Stent malapposition and the risk of stent thrombosis:mechanistic insights from an in vitro model[J]. EuroIntervention,2017,13(9):e1096-e1098.
[7] Ozaki Y,Okumura M,Ismail TF,et al. The fate of incomplete stent apposition with drug-eluting stents:an optical coherence tomography-based natural history study[J]. Eur Heart J,2010,31(12):1470-1476.
[8] Adriaenssens T,Joner M,Godschalk TC,et al. Optical coherence tomography findings in patients with coronary stent thrombosis:a report of the PRESTIGE consortium (prevention of late stent thrombosis by an interdisciplinary global european effort)[J]. Circulation,2017,136(11):1007-1021.
[9] Prati F,Romagnoli E,La Manna A,et al. Long-term consequences of optical coherence tomography findings during percutaneous coronary intervention:the centro per la lotta contro l’infarto-optimization of percutaneous coronary intervention (CLI-OPCI) LATE study[J]. EuroIntervention,2018,14(4):e443-e451.
[10] Lee SY,Im E,Hong SJ,et al. Severe acute stent malapposition after drug-eluting stent implantation:effects on long-term clinical outcomes[J]. J Am Heart Assoc,2019,8(13):e012800.
[11] Lombardi M,Chiabrando JG,Romagnoli E,et al. Impact of acute and persistent stent malapposition after percutaneous coronary intervention on adverse cardiovascular outcomes[J]. Minerva Cardiol Angiol,2023,71(5):525-534.
[12] Kim BG,Kachel M,Kim JS,et al. Clinical implications of poststent optical coherence tomographic findings:severe malapposition and cardiac events[J]. JACC Cardiovasc Imaging,2022,15(1):126-137.
[13] Ali ZA,Karimi Galougahi K,Shlofmitz RA,et al. The "oculo-appositional reflex":should optical coherence tomography-detected stent malapposition be corrected?[J]. J Am Heart Assoc,2019,8(7):e012262.
[14] Hong SJ,Park KH,Ahn CM,et al. Severe acute stent malapposition follow-up:3-month and 12-month serial quantitative analyses by optical coherence tomography[J]. Int J Cardiol,2020,299:81-86.
[15] R?ber L,Mintz GS,Koskinas KC,et al. Clinical use of intracoronary imaging. Part 1:guidance and optimization of coronary interventions. An expert consensus document of the european association of percutaneous cardiovascular interventions[J]. Eur Heart J,2018,39(35):3281-3300.
[16] Gutiérrez-Chico JL,Wykrzykowska J,Nüesch E,et al. Vascular tissue reaction to acute malapposition in human coronary arteries:sequential assessment with optical coherence tomography[J]. Circ Cardiovasc Interv,2012,5(1):20-9,S1-S8.
[17] 中华医学会心血管病学分会. 冠状动脉生物可吸收支架临床应用中国专家共识[J]. 中华心血管病杂志,2020,48(5):350-358.
[18] Foin N,Gutiérrez-Chico JL,Nakatani S,et al. Incomplete stent apposition causes high shear flow disturbances and delay in neointimal coverage as a function of strut to wall detachment distance: implications for the management of incomplete stent apposition[J]. Circ Cardiovasc Interv,2014,7(2):180-189.
[19] Soeda T,Uemura S,Park SJ,et al. Incidence and clinical significance of poststent optical coherence tomography findings:one-year follow-up study from a multicenter registry[J]. Circulation,2015,132(11):1020-1029.
[20] Sanuki Y,Sonoda S,Muraoka Y,et al. Contribution of poststent irregular protrusion to subsequent in-stent neoatherosclerosis after the second-generation drug-eluting stent implantation[J]. Int Heart J,2018,59(2):307-314.
[21] Bryniarski KL,Tahk SJ,Choi SY,et al. Clinical,angiographic,IVUS,and OCT predictors for irregular protrusion after coronary stenting[J]. EuroIntervention,2017,12(18):e2204-e2211.
[22] Sohn J,Hur SH,Kim IC,et al. A comparison of tissue prolapse with optical coherence tomography and intravascular ultrasound after drug-eluting stent implantation[J]. Int J Cardiovasc Imaging,2015,31(1):21-29.
[23] Sugiyama T,Kimura S,Ohtani H,et al. Relationship between quantities of tissue prolapse after percutaneous coronary intervention and neointimal hyperplasia at follow-up on serial optical coherence tomography examination[J]. Int J Cardiol,2017,241:470-477.
[24] Qiu F,Mintz GS,Witzenbichler B,et al. Prevalence and clinical impact of tissue?protrusion after stent implantation:an ADAPT-DES intravascular ultrasound substudy[J]. JACC Cardiovasc Interv,2016,9(14):1499-1507.
[25] Choi SY,Witzenbichler B,Maehara A,et al. Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction:a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy[J]. Circ Cardiovasc Interv,2011,4(3):239-247.
[26] Sakai S,Sato A,Hoshi T,et al. In vivo evaluation of tissue protrusion by using optical coherence tomography and coronary angioscopy immediately after stent implantation[J]. Circ J,2020,84(12):2235-2243.
[27] Kyodo A,Soeda T,Okamura A,et al. Clinical impact of irregular protrusion angle after coronary stenting at culprit lesions with ST-elevation myocardial infarction-an intravascular optical coherence tomography study[J]. Circ Rep,2021,3(8):431-439.
[28] Miura T,Sonoda S,Sanuki Y,et al. Comparison of post-stent irregular protrusion and subsequent neointimal characteristics between second-and third-generation drug-eluting stent implantation[J]. J Cardiol,2020,76(5):464-471.
[29] Yonetsu T,Hoshino M,Lee T,et al. Plaque morphology assessed by optical coherence tomography in the culprit lesions of the first episode of acute myocardial infarction in patients with low low-density lipoprotein cholesterol level[J]. J Cardiol,2020,75(5):485-493.
[30] Hou J,Xing L,Jia H,et al. Comparison of intensive versus moderate lipid-lowering therapy on fibrous cap and atheroma volume of coronary lipid-rich plaque using serial optical coherence tomography and intravascular ultrasound imaging[J]. Am J Cardiol,2016,117(5):800-806.
[31] Kubo T,Shinke T,Okamura T,et al. Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial):one-year angiographic and clinical results[J]. Eur Heart J,2017,38(42):3139-3147.
[32] Otake H,Kubo T,Takahashi H,et al. Optical Frequency domain imaging versus intravascular ultrasound in percutaneous coronary intervention (OPINION trial):results from the OPINION imaging study[J]. JACC Cardiovasc Imaging,2018,11(1):111-123.
[33] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 光学相干断层成像技术在冠心病介入诊疗中应用的中国专家共识[J]. 中华心血管病杂志,2023,51(2):109-124.
[34] Ann SH,Lim KH,De Jin C,et al. Multi-modality imaging for stent edge assessment[J]. Heart Vessels,2015,30(2):162-168.
[35] Chamié D,Bezerra HG,Attizzani GF,et al. Incidence,predictors,morphological characteristics,and clinical outcomes of stent edge dissections detected by optical?coherence tomography[J]. JACC Cardiovasc Interv,2013,6(8):800-813.
[36] Bouki KP,Sakkali E,Toutouzas K,et al. Impact of coronary artery stent edge dissections on long-term clinical outcome in patients with acute coronary syndrome:an optical coherence tomography study[J]. Catheter Cardiovasc Interv,2015,86(2):237-246.
[37] Palmerini T,Benedetto U,Biondi-Zoccai G,et al. Long-term safety of drug-eluting and?bare-metal stents:evidence from a comprehensive network meta-analysis[J]. J Am Coll Cardiol,2015,65(23):2496-2507.
[38] Jinnouchi H,Sakakura K,Yanase T,et al. Impact of stent edge dissection detected by optical coherence tomography after current-generation drug-eluting stent implantation[J]. PLoS One,2021,16(11):e0259693.
[39] Stone GW,Rizvi A,Newman W,et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease[J]. N Engl J Med,2010,362(18):1663-1674.
[40] Kobayashi N,Mintz GS,Witzenbichler B,et al. Prevalence,features,and prognostic importance of edge dissection after drug-eluting stent implantation:an ADAPT-DES intravascular ultrasound substudy[J]. Circ Cardiovasc Interv,2016,9(7):e003553.
[41] Prati F,Romagnoli E,Gatto L,et al. Clinical Impact of suboptimal stenting and residual intrastent plaque/thrombus protrusion in patients with acute coronary syndrome:the CLI-OPCI ACS Substudy (centro per la lotta contro l’infarto-optimization of percutaneous coronary intervention in acute coronary syndrome)[J]. Circ Cardiovasc Interv,2016,9(12):e003726.
[42] Radu MD,R?ber L,Heo J,et al. Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation[J]. EuroIntervention,2014,9(9):1085-1094.
[43] Prati F,Romagnoli E,Biccirè FG,et al. Clinical outcomes of suboptimal stent deployment as assessed by optical coherence tomography:long-term results of the CLI-OPCI registry [J]. EuroIntervention,2022,18(2):e150-e157.
[44] Ali ZA,Landmesser U,Maehara A,et al. Optical coherence tomography-guided versus angiography-guided PCI[J]. N Engl J Med,2023,389(16):1466-1476.
[45] van Zandvoort LJC,Tomaniak M,Tovar Forero MN,et al. Predictors for clinical outcome of untreated stent edge dissections as detected by optical coherence tomography[J]. Circ Cardiovasc Interv,2020,13(3):e008685.